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A B S T R A C T
It has been well documented that Zika virus (ZIKV) can be sexually transmitted. Dengue virus (DENV) shows
many similarities with ZIKV; both belong to the genus Flavivirus and share the same main vector route of
transmission. Moreover, they share overall architectural features on a molecular level, with a highly similar
structure and distinctive insertions, deletions and mutations of their respective E proteins, and it has been
suggested that they use a common pathophysiological pathway. In view of similarities with other sexually
transmissible viruses, the question arises as to whether DENV could also be sexually transmissible.
Limited animal model data do not suggest otherwise. The presence of dengue virus in - and human-to-human,
non-vector transmission from - various bodily fluids other than semen or vaginal secretions has been docu-
mented anecdotally.
Several anecdotal reports described prolonged presence of DENV in semen, urine and vaginal secretions. In
2019, two cases of likely sexual transmission were reported from Spain and South Korea, respectively.
We discuss the evidence for and against a relevant DENV sexual transmission potential, highlight con-
troversies and propose a future research agenda on this issue.
1. Introduction
Today, about 3.9 billion people, 52% of the world's population in
over 100 countries, live in dengue virus (DENV) endemic areas. It is
estimated that there are around 390 million DENV infections annually
[1,2]. Over the past decades, population growth, urbanisation and
globalisation have allowed DENV to spread and dramatically increase
in incidence [3,4]. Apart from vector control measures, interventions
against dengue have shown low efficacy.
Behavioural aspects of populations at risk may play a critical role in
control strategies [4]. To optimise control and intervention strategies,
potential routes of transmission of DENV need to be identified.
DENV is primarily transmitted via mosquito vectors: predominantly
Aedes aegypti, and to a lesser extent Aedes albopictus. However, other
modes of transmission have been anecdotally documented: via
mucocutaneous transmission, via needle stick injury in patient care and
laboratory accidents, via blood transfusion, via bone marrow trans-
plantation, via organ transplantation, as well as peripartal, perinatal
and via breastfeeding [5–7].
There are two striking recent examples for the ‘discovery’ of sexual
transmissibility of viruses not known before to have this potential.
First, during the large West-African Ebola virus disease (EVD) out-
break, the potential of this filoviral disease for sexual transmission was
recognised for the first time [8]. By now, it is established that live Ebola
virus (EBV) can be transmitted by male individuals up to years after
their clinical recovery from EVD [9].
Secondly and relevant here, in early 2015, ZIKV spread epidemi-
cally across the tropical and subtropical parts of the Americas and it
soon became clear that ZIKV can be sexually transmitted [10]. To date,
more than 35 cases of sexual transmission have been documented [11].
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DENV shares many similarities with Zika virus (ZIKV); both belong to
the genus flavivirus and share the same main route of transmission. They
share the same Aedes mosquito vectors and show similarity of the
overall structural architecture on a molecular level [12,13], with a
highly similar structure but distinctive insertions, deletions and muta-
tions of the E proteins [14]. Both ZIKV and DENV show inhibition of the
extracellular matrix (ECM) pathway, which suggests there is a common
pathophysiological pathway [15]. In view of these similarities, the
question whether DENV is sexually transmissible, too, is evident.
Furthermore, there were two reports of detection of other flavi-
viruses including chikungunya virus and yellow fever virus in semen up
to 30 days and 21 days after symptom onset, respectively [16,17].
All this raises the question if there is more to explore with relation
to sexual transmission of arboviruses as a recent publication eloquently
put it [18].
2. Evidence for and against DENV sexual transmission potential
2.1. Sexual transmission potential of viruses in general
Salam and Horby reviewed the sexual transmission potential of a
broad range of viruses pathogenic to man [19]. Their search identified
27 viruses (from 13 families) which were shown to be detectable in
semen, 13 of which had also been isolated. Evidence for actual sexual
transmission was found for HIV, hepatitis A (HAV), B (HBV) and C
(HCV), herpes simplex viruses (HSV) 1 and 2; cytomegalovirus (CMV),
ZIKV, and EBOV. In men having sex with men (MSM), HAV, HBV, HCV
transmission are of particular importance [20,21]. Counotte et al. also
summarised some evidence for anecdotal West Nile virus (WNV) sexual
transmission [11].
2.2. DENV structural considerations
With DENV and ZIKV sharing structural and biochemical properties
[12–15], Goo and colleagues [22] assessed the relative stability of
ZIKV, DENV and WNV, by measuring changes in infectivity following
prolonged incubation at physiological temperatures. Their findings
suggest that whilst the half-lives of the flaviviruses differ (ZIKV 11.8 h;
DENV 5.2 h), structural E-protein variations had no measurable impact
on the stability of the respective viruses in the experiments. Overall, the
similarities of the viruses indicate that perhaps DENV can survive the
same harsh environments (semen, vaginal fluid) as ZIKV, which is a pre-
requisite for virus viability and replicability following sexual trans-
mission.
2.3. Evidence from animal models
To the best of our knowledge, data derived from animal models are
scarce. Some abstracts, but otherwise unpublished data, describe a
small cohort of pigtail macaques experimentally infected with DENV-3
and demonstrate virus recovery from prostate glands and seminal ve-
sicles [23].
2.4. Presence of DENV in human body fluids other than blood, and
alternative routes of transmission of DENV
Back in 2004, Chen and Wilson [5] reported a case of dengue fever
in a US healthcare worker who had no recent history of travel outside
Northeastern United States. The source of infection was presumed to be
a febrile traveller who had recently returned from Peru. The health care
worker was transferring the blood of the traveller from a syringe to a
blood culture bottle when the needle dislodged from the syringe,
splashing blood onto her face. Although molecular proof was lacking,
sequential serologic testing of index and secondary patient, in con-
junction with circumstantial evidence, rendered nosocomial transmis-
sion from blood onto mucous membranes as the only plausible route of
transmission.
In the same paper, the authors summarised, and later updated [7],
published information on non-vectorial DENV transmission; high-
lighting that, except for sexual transmission, albeit only anecdotally,
merely all routes of non-vector borne transmission of DENV have been
shown to exist, from mucocutaneous to percutaneous to intrapartum or
vertical transmission, and via bone marrow and solid organ trans-
plantation [11].
In 2017, Iannetta et al. [24] reported on a woman returning to Italy
from Sri Lanka with confirmed dengue fever. DENV RNA could be
isolated from all body fluids tested (urine, saliva, vaginal secretion),
with DENV remaining detectable in vaginal secretions up to 18 days
after onset of symptoms.
In 2018, Lalle et al. [25] reported on a man returning to Italy from
Thailand, where he had been diagnosed with dengue, using a com-
mercial rapid test. This diagnosis was confirmed in Italy on day 9 fol-
lowing symptom onset (FSO), by detection of dengue RNA and specific
IgM and IgG in serum. Virological follow-up was performed on semen
and urine samples that were positive at admission (day 9). Urine
samples were negative after day 24, while semen samples remained
positive until day 55.
Molton and colleagues [26] examined semen specimen obtained
between days 4 and 6 FSO, in a cohort of five male dengue patients
from Singapore, all diagnosed between 3 and 6 days FSO (with the
diagnoses based on clinical findings, NS1 positivity, and in 3/5 cases a
positive serum PCR). Semen specimen from all 5 men were qualitative
DENV-PCR negative. This was not surprising, since virus kinetics data
suggest a later appearance in, and disappearance from, urine than in
blood [27]. It could be argued that the same holds true for semen. In the
study by Molton et al., all patients fell ill shortly before specimen col-
lection; moreover, the viral loads were undetectable in the two serum
PCR-negative individuals and allegedly low in the three others. Thus,
the timing of semen collection could have been too early to detect virus,
which means that a study with a longer period of follow-up is war-
ranted, to conclude whether or not DENV is able to appear and survive
in semen.
Virus kinetics suggest that after an early viraemia peak in blood,
followed by rapid clearance after a couple of days, DENV is detectable
with an ill-defined delay in urine, which can be as early as from two
days FSO to more than a month later. Based on dengue virus recovery
studies from urine samples by real-time PCR in a small cohort of pa-
tients from Belgium, it is suggested that, in general, DENV RNA con-
centrations are higher in serum than in urine during the first week FSO.
Thereafter, virus concentrations in urine might exceed those in serum,
peaking around day 10 FSO and then fading away, becoming un-
detectable between three and four weeks in most cases. This line of
reasoning suggests that one would expect a delay between the blood
viraemia peak and the appearance of virus in other body fluids, in-
cluding semen. This implies that a systematic study of presence or ab-
sence of DENV from semen during or after a dengue fever episode in
male patients should encompass sequential serum, (urine) and semen
testing by (ideally quantitative) PCR for a prolonged period of at least
3–4 weeks.
2.5. Evidence of human-to-human sexual transmission
At the end of 2019, a report from Spain, described likely sexual
transmission of dengue between men who have sex with men (MSM)
and provided epidemiological, clinical and molecular diagnostic evi-
dence (the latter not reported in detail) for sexual transmission [28].
The index patient had travelled to Cuba and afterwards to the Domin-
ican Republic for about a week in total. He became ill immediately after
return to Spain. Having had sex with the index patient on day 4 FSO,
the second patient fell ill about a week after exposure. From both pa-
tients, semen samples tested DENV positive; and sequencing, according
to the report, yielded genetically fully identical viruses. With the second
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patient not having visited a dengue-endemic area within the incubation
period, in conjunction with other circumstantial evidence, it was con-
cluded that sexual transmission was by far the most likely mode of
DENV transmission.
Finally, a recent report from South Korea [29] offered anecdotal but
strong epidemiological, clinical and molecular diagnostic evidence for
female-to-male sexual transmission of DENV in a couple from South
Korea. In this case, the index patient had visited Indonesia, fell ill
around the time of return, and had sex with a partner who had not
visited a dengue-endemic area recently, falling ill nine days after the
sexual intercourse. From both patients, DENV type 1 was isolated from
serum, and genotyping demonstrated identical virus. With alternative
routes of transmission (e.g. blood-mucosa contact) being impossible to
be entirely excluded; as in the case reported from Spain, sexual trans-
mission was considered most likely, if not definitive.
3. Controversies
The evidence, presented above, clearly shows possible sexual
transmission of dengue. But to what extent does this occur and is this of
public health significance? Table 1 summarises the evidence to date. In
view of the fact that sexual transmission of dengue to partners of ill-
returning travelers to non-endemic countries has so rarely been re-
ported and given the considerable number of dengue cases in returning
travelers [30], it is highly unlikely that such a route of transmission of
relevance would have slipped notice on a global scale until recently. On
the other hand, reports and data now begin to accumulate, which
support the sexual (genital) transmission of DENV virus amongst part-
ners, in line with reports on other alternative (non-vectorial) modes of
transmission.
Perhaps it is useful to put this risk into perspective by comparing it
to the transmission efficacy of known viral STDs, such as HBV, HCV or
HIV. Heterosexual transmission of HBV outside a sex work context
reaches 40% for non-immune partners and around 0,5%–2% per year of
relationship for HCV [31]. The risk for HIV is estimated to be in the
region of 0.4–1.4% per sexual exposure [32]. Furthermore, it is well
known, certainly from the case of HIV-infection, that certain risk factors
may increase sexual transmission [33]. However, information on this is
scarce from the two well-documented cases of DENV sexual transmis-
sion where such risk factors were not identified in both cases but where
the paucity of data renders any conclusions speculative.
Virological data aiming at deducing the sexual transmission pro-
pensity from biochemical and molecular structural characteristics are
not contradicting the DENV potential to be transmitted via genital
contact. Transmission of virus material does not equal transmission of
‘viable’ virus able to reproduce after transmission as pointed out in an
editorial on a publication on ZIKA virus, where only 4% of RNA-posi-
tive semen was found to be infectious, with a minimum of log10 RNA
copies/mL [34].
4. Future research
Animal experimental data demonstrating sexual transmission of
viable DENV capable of reproduction in the receiving partner are
lacking, and data suggesting this route of transmission in humans are to
date, confined to two anecdotal reports. Epidemiological studies on
human-to-human transmission in this area will be very challenging to
perform. Perhaps, the best way forward would be a well-designed,
prospective, long-term, multicentre study amongst collaborating travel
clinics looking systematically into DENV expression in semen and va-
ginal fluid during and after an acute disease episode. This would be an
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